Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04064801
Recruitment Status : Not yet recruiting
First Posted : August 22, 2019
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
Barış Arslan, Adana Numune Training and Research Hospital

Brief Summary:
aim to investigate the relationship between the RDW and 7-day mortality during acute methanol poisoning.

Condition or disease
Methane Poisoning

Detailed Description:
RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning
Estimated Study Start Date : September 15, 2019
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : October 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Poisoning




Primary Outcome Measures :
  1. 7-day mortality [ Time Frame: 7 day ]
  2. Length of mechanical ventilation [ Time Frame: 1 day ]
  3. hospital discharge length [ Time Frame: 7 day ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 88 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with acute methanol toxicity who were diagnosed and treated at the Adana City Training and Research Hospital, Mersin City Training and Research Hospital.
Criteria

Inclusion Criteria:

All patients aged ≥16 years who were admitted to both emergency departments from January 2018 to September 2019 on account of acute methanol intoxication.

Exclusion Criteria:

prehospital cardiac arrest transfer to another hospital

-

Layout table for additonal information
Responsible Party: Barış Arslan, Adana City Training and Research Hospital, Adana Numune Training and Research Hospital
ClinicalTrials.gov Identifier: NCT04064801    
Other Study ID Numbers: AdanaCTYHOSP
First Posted: August 22, 2019    Key Record Dates
Last Update Posted: August 22, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Poisoning
Chemically-Induced Disorders